Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Targeting Non-Apoptotic Cell Death in Cancer Treatment by Nanomaterials: Recent Advances and Future Outlook Publisher Pubmed



Sepand MR1 ; Ranjbar S2 ; Kempson IM3, 4 ; Akbariani M1 ; Muganda WCA5 ; Muller M5 ; Ghahremani MH1 ; Raoufi M2, 5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Nanotechnology Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Future Industries Institute, University of South Australia, Mawson Lakes, SA, Australia
  4. 4. School of Pharmacy and Medical Sciences, University of South Australia, SA, Australia
  5. 5. Physical Chemistry I and Research Center of Micro and Nanochemistry (Cμ), University of Siegen, Siegen, Germany

Source: Nanomedicine: Nanotechnology# Biology# and Medicine Published:2020


Abstract

Many tumors develop resistance to most of the apoptosis-based cancer therapies. In this sense targeting non-apoptotic forms of cell death including necroptosis, autophagy and ferroptosis may have therapeutic benefits in apoptosis-defective cancer cells. Nanomaterials have shown great advantages in cancer treatment owing to their unique characteristics. Besides, the capability of nanomaterials to induce different forms of cell death has gained widespread attention in cancer treatment. Reports in this field reflect the therapeutic potential of necroptotic cell death induced by nanomaterials in cancer. Also, autophagic cell death induced by nanomaterials alone and as a part of chemo-, radio- and photothermal therapy holds great promise as anticancer therapeutic option. Besides, ferroptosis induction by iron-based nanomaterials in drug delivery, immunotherapy, hyperthermia and imaging systems shows promising results in malignancies. Hence, this review is devoted to the latest efforts and the challenges in this field of research and its clinical merits. © 2020 Elsevier Inc.
Other Related Docs
24. Application of Nano-Radiosensitizers in Combination Cancer Therapy, Bioengineering and Translational Medicine (2023)
29. Cancer Nanomedicine: Special Focus on Cancer Immunotherapy, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
31. Biocompatibility and Nanostructured Materials: Applications in Nanomedicine, Artificial Cells# Nanomedicine and Biotechnology (2017)
34. Nanozymes With Intrinsic Peroxidase-Like Activities, Journal of Molecular Liquids (2019)
37. Potential of Nanoparticles and Nanopolymers in Treatment of Age-Associated Diseases, Advances in Natural Sciences: Nanoscience and Nanotechnology (2021)
40. Exosomes, Autophagy and Er Stress Pathways in Human Diseases: Cross-Regulation and Therapeutic Approaches, Biochimica et Biophysica Acta - Molecular Basis of Disease (2022)
41. Virus, Exosome, and Microrna: New Insights Into Autophagy, Advances in Experimental Medicine and Biology (2022)
43. Toxicity of Inorganic Nanoparticles, Comprehensive Analytical Chemistry (2022)
44. Commercial and Regulatory Challenges in Cancer Nanomedicine, Functionalized Nanomaterials for Cancer Research: Applications in Treatments# Tools and Devices (2024)
46. Emerging Role of Mirnas in the Regulation of Ferroptosis, Frontiers in Molecular Biosciences (2023)